Home Market

Market

Jan Aushadhi scheme may disrupt domestic pharma market

New Delhi, March 20, 2019: The Jan Aushadhi scheme, under which the government provides quality medicines at affordable rates may disrupt around 20 percent of Indian pharmaceutical market sales, says a report. According to reports published in moneycontrol.com The scheme aims...

FY20 Pharma Outlook: Margin Recovery in Sight; Investment Requirements to Remain High

Ind-Ra-Chennai, February 19, 2019: India Ratings and Research (Ind-Ra) has maintained a stable outlook on the Indian pharmaceutical sector due to the expected recovery in margins, improved cash generation on the back of emerging pricing stability in the US generic...

Kuwait Hospital Market Outlook to 2022: Ken Research

New Delhi, January 26, 2019: The report titled “Kuwait Hospital Market Outlook to 2022- By Public and Private Hospitals, By Inpatients and Outpatients, By General and Specialty Hospital and By Region (Al Asima, Hawalli, Al Farwaniya, Al Ahmadi, Al...

Share market update: Pharma shares gain; Piramal Enterprises up 1%

New Delhi, January 16, 2019: Pharma shares were trading with gains in Tuesday's morning trading session. Shares of Piramal Enterprises (up 1.25 per cent), Lupin (up 1.07 per cent), Cadila Healthcare (up 0.88 per cent) and Aurobindo Pharma (up 0.55...

‘Enjoyable forms’ to see major contract services growth in 2019

Demand in China driven by emerging consumer demand, but in the USA and EU growth triggered by market maturation.  New Delhi, January 08, 2019: Sirio Pharma Co. Ltd (SIRIO) – the global nutraceutical contract development, innovation and manufacturing organization (CDiMO) – forecasts considerable...

Eisai’s New Drug Application for Perampanel Designated for Priority Review by China National Medical...

For Adjunctive Treatment of Partial Onset Seizures Tokyo, January 05, 2019: Eisai Co., Ltd. announced that its in-house discovered and developed antiepileptic drug (AED) perampanel (generic name, product name: Fycompa), for which a New Drug Application (NDA) was submitted for...

LANXESS completes sale of ARLANXEO to Saudi Aramco

Cologne-based company received proceeds of around EUR 1.4 billion Cologne, January 04, 2019:  Specialty chemicals company LANXESS today, December 31, 2018, completed the sale of its remaining 50 percent interest in the rubber company ARLANXEO to Saudi Aramco. All relevant...

India Coupling Agents & Compatibilizers Market Outlook to 2023: Ken Research

New Delhi, January 04, 2018: The report titled “India Coupling Agents & Compatibilizers Market Outlook to 2023 - By Application (Packaging & Plastics Industry, Automotives Industry, Adhesives & Sealants and Paints & Coatings, Rubber Industry, Energy Sector and Others) and...

Expertise in efficient, selective and safe reactions 100 years “Catalyst Laboratory” in Leverkusen

New Delhi, January 02, 2019: Cologne – The “Catalyst Laboratory” was founded 100 years ago in Leverkusen – where the CHEMPARK is located today. At that time, the scope of activities was outlined as “work on catalytic reactions involving organic...

Philippines Nutraceuticals Market Outlook to 2022 : Ken Research

New Delhi, January 02, 2018: The report titled “Philippines Nutraceuticals Market Outlook to 2022 – Composite Herbal Dietary Ingredients, Ginseng, Garlic and Ginkgo Biloba Based Herbal Supplements will Drive the Growth” provides a comprehensive analysis of the nutraceuticals market...